Comprehensive Mounjaro vs Wegovy Analysis: Every Dose Explained
What Is Better Mounjaro or Wegovy: Understanding Complete Dose Availability
When comparing Mounjaro versus Wegovy, having access to every dose throughout your treatment journey is crucial for success. EverydayMeds stocks the complete Wegovy escalation pathway: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance dose from week 17 onwards. This comprehensive availability means you'll never face treatment interruption due to supply issues. Similarly, we maintain full Mounjaro inventory across all licensed doses, ensuring your prescriber's choice between these treatments isn't limited by pharmacy stock levels.
The question of what is better Mounjaro or Wegovy becomes less about theoretical superiority and more about practical access to your prescribed dose when you need it. Our Ultimate Stability Trio bundle provides three months of 2.4mg maintenance supply for £649.99, whilst our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg for £169.99) ensure smooth treatment initiation. This complete dose ecosystem supports your entire weight management journey from a single, trusted pharmacy registered with the GPhC #9012878.
Wegovy vs Mounjaro Pricing: All Doses With Transparent Costs
Understanding the financial commitment for either treatment requires knowing costs across all dose levels, not just starter pricing. Wegovy pricing at EverydayMeds ranges from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance dose, with our FIRST40 discount code for new customers and DOSE25 for returning patients applied at checkout. Our step-up bundles provide convenience and supply security: the Progress Trio (0.5mg, 1mg & 1.7mg) costs £369.99, covering months 2-4 of treatment in a single order.
When considering what is better Mounjaro or Wegovy from a cost perspective, both require long-term commitment with dose escalation protocols. Our Consistency bundles offer extended supply at each dose level—for instance, Consistency 1mg (×2 pens) at £209.99 for patients who need extended time at their current dose before escalation. This pricing transparency across all doses helps patients and prescribers make informed decisions about which treatment pathway suits both clinical needs and financial planning for sustained weight management.
Clinical Evidence: Mounjaro vs Wegovy Treatment Outcomes
In clinical trials, Wegovy demonstrated significant weight management potential through the STEP trial programme. STEP 1 showed participants achieving an average of approximately clinically studied weight loss at 68 weeks when used alongside a reduced-calorie diet and increased physical activity, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT trial additionally demonstrated a 20% reduction in major cardiovascular events with semaglutide treatment.
When evaluating what is better Mounjaro or Wegovy clinically, both treatments have shown efficacy in separate trial programmes with different study designs and participant populations. Mounjaro's dual mechanism targeting both GIP and GLP-1 receptors offers a different approach to appetite regulation compared to Wegovy's GLP-1-only mechanism. Your prescriber can assess which mechanism may be more suitable based on your individual medical history, current medications, and treatment goals during your clinical assessment.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone involved in appetite regulation and glucose metabolism. This prescription-only medicine works by binding to GLP-1 receptors in the brain's appetite centres, promoting feelings of fullness and reducing food cravings after smaller meals. The once-weekly injection via FlexTouch pen provides sustained hormone levels throughout the week, supporting consistent appetite management. Additionally, Wegovy may slow gastric emptying, helping you feel satisfied for longer periods after eating. This mechanism makes Wegovy particularly effective when combined with a reduced-calorie diet and increased physical activity, as recommended in its licensed indication for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidity.
Complete Treatment Journey: Assessment to Maintenance Dose
Starting your weight management journey with either Wegovy or Mounjaro begins with our 3-minute online clinical assessment, reviewed by qualified prescribers within 3 working days (or 24 hours with our express service). Once approved, your first dose ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. Our complete dose availability means your second month's prescription can often be processed simultaneously, reducing delays in dose escalation. As you progress from starter doses through to maintenance, our bundle options like the Elevate Trio (1mg, 1.7mg & 2.4mg) for £499.99 ensure seamless continuation. This streamlined process, supported by our GPhC #9012878 registration, eliminates common barriers to sustained weight management treatment.
Storage and Practical Considerations: Wegovy vs Mounjaro Differences
Storage requirements can influence the choice between treatments, particularly for frequent travellers or those with limited refrigeration. Wegovy offers superior storage flexibility, remaining stable for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both treatments require refrigeration at 2-8°C before first use and utilise pre-filled injection pens for convenient once-weekly dosing. The FlexTouch pen system used with Wegovy includes dose confirmation features and needle safety mechanisms. Understanding these practical differences helps answer what is better Mounjaro or Wegovy for your lifestyle, particularly regarding travel, work schedules, or household storage constraints.
What Is Better Mounjaro or Wegovy: Complete Dose Range Strategy
Having every dose available eliminates a common treatment barrier: pharmacy switching during critical escalation phases. Many patients experience treatment disruption when their pharmacy lacks their next prescribed dose, potentially affecting treatment continuity and outcomes. Our comprehensive inventory strategy ensures you establish a relationship with one pharmacy team who understand your treatment history and individual needs. This continuity becomes particularly valuable during maintenance phase, where patients may require dose adjustments or extended supply planning.
The question what is better Mounjaro or Wegovy often resolves to which treatment you can access reliably throughout your entire journey. Our Take-It-Slow bundles accommodate patients who need extended time at lower doses, whilst our maintenance bundles support long-term treatment planning. This complete ecosystem approach means your treatment choice focuses on clinical suitability rather than supply constraints, supporting the best possible outcomes from your chosen therapy.
Expert Prescription Service: Making the Right Treatment Choice
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns with your medical history, current medications, and weight management goals. Our clinical team reviews each assessment individually, considering factors like previous weight management attempts, underlying health conditions, and practical lifestyle considerations. New customers can begin their clinical assessment today using discount code FIRST40, whilst returning patients benefit from DOSE25 applied at checkout. With next-day delivery and complete dose availability, your personalised weight management journey can begin promptly once approved. Visit https://everydaymeds.co.uk/collections/wegovy to start your clinical assessment and access the UK's most comprehensive weight management prescription service.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
